Technical Articles

靶向ActRIIB的新型7-氮杂吲哚小分子抑制剂:攻克肿瘤恶病质的新策略
Novel 7-Azaindole Small Molecule Inhibitors Targeting ActRIIB: A New Strategy to Tackle Cancer Cachexia
发布时间 2025-10-28
ActRIIB (Activin Type IIB Receptor) and ACTRIIA (Activin Type IIA Receptor) are structurally similar transmembrane receptors belonging to the TGF-β receptor superfamily. They collectively function to receive extracellular "growth regulatory signals," yet exhibit key distinctions in their physiological roles and their value as drug targets.
View details
  • Drug Research
  • ActRIIB
  • ACTRIIA
  • TGF-β receptor
  • UA BIOSCIENCE
  • UA Protein
Total 1
  • 1
Go to